Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Gross Profit (2016 - 2026)

Amphastar Pharmaceuticals has reported Gross Profit over the past 13 years, most recently at $85.7 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 1.13% year-over-year to $85.7 million; the TTM value through Dec 2025 reached $356.1 million, down 4.76%, while the annual FY2025 figure was $356.1 million, 4.76% down from the prior year.
  • Gross Profit for Q4 2025 was $85.7 million at Amphastar Pharmaceuticals, down from $98.6 million in the prior quarter.
  • Over five years, Gross Profit peaked at $108.4 million in Q3 2023 and troughed at $44.9 million in Q1 2021.
  • A 5-year average of $76.5 million and a median of $79.5 million in 2023 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: soared 85.27% in 2023 and later decreased 9.87% in 2024.
  • Year by year, Gross Profit stood at $56.2 million in 2021, then rose by 26.56% to $71.2 million in 2022, then surged by 35.09% to $96.1 million in 2023, then dropped by 9.87% to $86.6 million in 2024, then decreased by 1.13% to $85.7 million in 2025.
  • Business Quant data shows Gross Profit for AMPH at $85.7 million in Q4 2025, $98.6 million in Q3 2025, and $86.5 million in Q2 2025.